126 related articles for article (PubMed ID: 8992631)
1. [The absence of autoantibodies does not rule out autoimmune hepatitis].
Schmid PA; Schwery S; Kupferschmidt H; Bühler H
Schweiz Med Wochenschr; 1996 Nov; 126(48):2090-3. PubMed ID: 8992631
[TBL] [Abstract][Full Text] [Related]
2. [Diagnosis and therapy of autoimmune hepatitis].
Heintges T; Mohr L; Niederau C; Strohmeyer G
Z Gastroenterol; 1995 Aug; 33(8):462-7. PubMed ID: 7483741
[TBL] [Abstract][Full Text] [Related]
3. Results of steroid-based therapy for the hepatitis C-autoimmune hepatitis overlap syndrome.
Schiano TD; Te HS; Thomas RM; Hussain H; Bond K; Black M
Am J Gastroenterol; 2001 Oct; 96(10):2984-91. PubMed ID: 11693337
[TBL] [Abstract][Full Text] [Related]
4. A comparison of the prevalence of autoantibodies in individuals with chronic hepatitis C and those with autoimmune hepatitis: the role of interferon in the development of autoimmune diseases.
Bayraktar Y; Bayraktar M; Gurakar A; Hassanein TI; Van Thiel DH
Hepatogastroenterology; 1997; 44(14):417-25. PubMed ID: 9164512
[TBL] [Abstract][Full Text] [Related]
5. [Autoimmune chronic hepatitis in children].
Nałecz A; Janowicz W; Pawłowska J; Socha J
Wiad Lek; 1989 Jul 1-15; 42(13-15):862-6. PubMed ID: 2634314
[TBL] [Abstract][Full Text] [Related]
6. Steroid therapy of chronic hepatitis: characteristics associated with response in anti-hepatitis C virus-positive and -negative patients.
Thiele DL; DuCharme L; Cunningham MR; Mimms LT; Cuthbert JA; Lee WM; Combes B
Am J Gastroenterol; 1996 Feb; 91(2):300-8. PubMed ID: 8607497
[TBL] [Abstract][Full Text] [Related]
7. [Experience with immunosuppressive therapy in chronic aggressive hepatitis].
Shimelpfenig V; Vagner K; Toier D; Shnaider G; Khekht A; Shimelpfenig R
Vutr Boles; 1972; 11(3):120-3. PubMed ID: 4679965
[No Abstract] [Full Text] [Related]
8. [Autoimmune hepatitis: clinical forms and related factors to their response to treatment].
Dávalos M; Román R; Bustios C; Zumaeta E; Yabar A
Rev Gastroenterol Peru; 2004; 24(4):305-13. PubMed ID: 15614298
[TBL] [Abstract][Full Text] [Related]
9. Evidence for spontaneous immunosuppression in autoimmune hepatitis.
Lohse AW; Kögel M; Meyer zum Büschenfelde KH
Hepatology; 1995 Aug; 22(2):381-8. PubMed ID: 7635404
[TBL] [Abstract][Full Text] [Related]
10. Autoimmune hepatitis in inflammatory bowel disease: report of two unusual cases.
Seibold F; Weber P; Jenss H; Scheurlen M
Z Gastroenterol; 1997 Jan; 35(1):29-32. PubMed ID: 9123955
[TBL] [Abstract][Full Text] [Related]
11. Development of autoimmune hepatitis in the setting of long-standing primary biliary cirrhosis.
Angulo P; El-Amin O; Carpenter HA; Lindor KD
Am J Gastroenterol; 2001 Oct; 96(10):3021-7. PubMed ID: 11693344
[TBL] [Abstract][Full Text] [Related]
12. Features of autoimmune hepatitis in primary sclerosing cholangitis: an evaluation of 114 primary sclerosing cholangitis patients according to a scoring system for the diagnosis of autoimmune hepatitis.
Boberg KM; Fausa O; Haaland T; Holter E; Mellbye OJ; Spurkland A; Schrumpf E
Hepatology; 1996 Jun; 23(6):1369-76. PubMed ID: 8675153
[TBL] [Abstract][Full Text] [Related]
13. Serologic markers do not predict histologic severity or response to treatment in patients with autoimmune hepatitis.
Mehendiratta V; Mitroo P; Bombonati A; Navarro VJ; Rossi S; Rubin R; Herrine SK
Clin Gastroenterol Hepatol; 2009 Jan; 7(1):98-103. PubMed ID: 18955163
[TBL] [Abstract][Full Text] [Related]
14. [Autoimmune chronic active hepatitis].
Renner EL
Ther Umsch; 1993 Feb; 50(2):100-9. PubMed ID: 8456413
[TBL] [Abstract][Full Text] [Related]
15. [Autoimmune hepatitis: recent update on diagnosis and treatment].
Lee YS
Korean J Hepatol; 2006 Sep; 12(3):318-32. PubMed ID: 16998286
[TBL] [Abstract][Full Text] [Related]
16. Cyclophosphamide as alternative immunosuppressive therapy for autoimmune hepatitis--report of three cases.
Kanzler S; Gerken G; Dienes HP; Meyer zum Büschenfelde KH; Lohse AW
Z Gastroenterol; 1997 Jul; 35(7):571-8. PubMed ID: 9273991
[TBL] [Abstract][Full Text] [Related]
17. Combination of steroid with azathioprine in treatment of giant cell autoimmune hepatitis.
Eroğlu Y; Düzovali O; Kavukçu S; Irken G; Büyükgebiz B
Turk J Pediatr; 1997; 39(4):565-71. PubMed ID: 9433162
[TBL] [Abstract][Full Text] [Related]
18. Autoimmune features as determinants of prognosis in steroid-treated chronic active hepatitis of uncertain etiology.
Czaja AJ; Davis GL; Ludwig J; Baggenstoss AH; Taswell HF
Gastroenterology; 1983 Sep; 85(3):713-7. PubMed ID: 6192038
[TBL] [Abstract][Full Text] [Related]
19. [Autoimmune hepatitis in children].
Stanković I; Zlatković M; Prokić D; Plamenac P
Srp Arh Celok Lek; 2000; 128(1-2):10-6. PubMed ID: 10916458
[TBL] [Abstract][Full Text] [Related]
20. Anti-cyclic citrullinated peptide antibodies in type 1 autoimmune hepatitis.
Fusconi M; Vannini A; Dall'Aglio AC; Pappas G; Cassani F; Ballardini G; Frisoni M; Grassi A; Bianchi FB; Zauli D
Aliment Pharmacol Ther; 2005 Nov; 22(10):951-5. PubMed ID: 16268969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
